Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension
- PMID: 25828847
- DOI: 10.1161/HYP.0000000000000018
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension
Erratum in
-
Correction.Hypertension. 2016 Oct;68(4):e61. doi: 10.1161/HYP.0000000000000051. Hypertension. 2016. PMID: 27605563 No abstract available.
Keywords: AHA Scientific Statements; blood pressure; coronary artery disease; epidemiology; hypertension; secondary prevention.
Similar articles
-
Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.J Am Soc Hypertens. 2015 Jun;9(6):453-98. doi: 10.1016/j.jash.2015.03.002. Epub 2015 Mar 31. J Am Soc Hypertens. 2015. PMID: 25840695 Review. No abstract available.
-
Implications of new hypertension guidelines in the United States.Hypertension. 2012 Sep;60(3):639-44. doi: 10.1161/HYPERTENSIONAHA.112.193714. Epub 2012 Aug 6. Hypertension. 2012. PMID: 22868391
-
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.Circulation. 2015 May 12;131(19):e435-70. doi: 10.1161/CIR.0000000000000207. Epub 2015 Mar 31. Circulation. 2015. PMID: 25829340 Free PMC article. No abstract available.
-
A New Guideline on Treatment of Hypertension in Those with Coronary Artery Disease: Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension About Treatment of Hypertension in Patients with Coronary Artery Disease.Heart Lung Circ. 2015 Nov;24(11):1037-40. doi: 10.1016/j.hlc.2015.05.022. Epub 2015 Jul 9. Heart Lung Circ. 2015. PMID: 26205991 Review.
-
Lifetime Risks for Hypertension by Contemporary Guidelines in African American and White Men and Women.JAMA Cardiol. 2019 May 1;4(5):455-459. doi: 10.1001/jamacardio.2019.0529. JAMA Cardiol. 2019. PMID: 30916719 Free PMC article.
Cited by
-
Comparative Proteomic and Phosphoproteomic Analyses Reveal Molecular Signatures of Myocardial Infarction and Transverse Aortic Constriction in Aged Mouse Models.Cardiol Res Pract. 2024 Oct 28;2024:9395213. doi: 10.1155/2024/9395213. eCollection 2024. Cardiol Res Pract. 2024. PMID: 39502510 Free PMC article.
-
Yangxinshi Tablet Improves Exercise Capacity for Patients with Coronary Heart Disease: Results from a Randomized, Double-Blind, Placebo-Controlled, and Multicenter Trial.Rev Cardiovasc Med. 2022 Jul 21;23(8):266. doi: 10.31083/j.rcm2308266. eCollection 2022 Aug. Rev Cardiovasc Med. 2022. PMID: 39076617 Free PMC article.
-
Emergency Neurosurgery in a Patient With Pacemaker: The Double Trouble.Cureus. 2024 Apr 14;16(4):e58256. doi: 10.7759/cureus.58256. eCollection 2024 Apr. Cureus. 2024. PMID: 38752029 Free PMC article.
-
The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines.Am J Cardiovasc Drugs. 2023 Nov;23(6):663-682. doi: 10.1007/s40256-023-00605-5. Epub 2023 Sep 5. Am J Cardiovasc Drugs. 2023. PMID: 37668854 Free PMC article. Review.
-
Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study.Adv Ther. 2023 Jun;40(6):2725-2740. doi: 10.1007/s12325-023-02462-9. Epub 2023 Apr 8. Adv Ther. 2023. PMID: 37029871 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
